Cargando…
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility
BACKGROUND: “Hospital-at-home” (HAH) programs have been shown to optimize resource utilization, shorten hospitalization and prevent nosocomial infection. METHODS: We retrospectively analysed data regarding implementation of an HAH unit for caring patients with hematological malignancies in our cente...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457036/ https://www.ncbi.nlm.nih.gov/pubmed/34553338 http://dx.doi.org/10.1007/s12185-021-03219-2 |
_version_ | 1784570995298795520 |
---|---|
author | Gómez-Centurión, Ignacio Oarbeascoa, Gillen García, María Carmen López Fresneña, María Carmen Martínez Carreño, María Josefa Escudero Vilaplana, Vicente González-Haba, Eva Bailén, Rebeca Dorado, Nieves Juárez, Luis Miguel Rodríguez Macías, Gabriela Font López, Patricia Encinas, Cristina Bastos-Oreiro, Mariana Anguita, Javier Sanjurjo, María Díez-Martin, José Luis Kwon, Mi |
author_facet | Gómez-Centurión, Ignacio Oarbeascoa, Gillen García, María Carmen López Fresneña, María Carmen Martínez Carreño, María Josefa Escudero Vilaplana, Vicente González-Haba, Eva Bailén, Rebeca Dorado, Nieves Juárez, Luis Miguel Rodríguez Macías, Gabriela Font López, Patricia Encinas, Cristina Bastos-Oreiro, Mariana Anguita, Javier Sanjurjo, María Díez-Martin, José Luis Kwon, Mi |
author_sort | Gómez-Centurión, Ignacio |
collection | PubMed |
description | BACKGROUND: “Hospital-at-home” (HAH) programs have been shown to optimize resource utilization, shorten hospitalization and prevent nosocomial infection. METHODS: We retrospectively analysed data regarding implementation of an HAH unit for caring patients with hematological malignancies in our center, during the COVID-19 pandemic. RESULTS: Between January and November 2020, 105 patients were treated in the HAH unit for a total of 204 episodes. Nine patients with multiple myeloma (MM) received autologous HSCT (auto-HSCT). Three patients with acute myeloid leukemia (AML) received consolidation therapy, 32 patients underwent clinical and analytical monitoring, 20 were transplant recipients early discharged (5 auto-HSCT and 15 allo-HSCT) and 2 had received CART cells therapy. Azacitidine, bortezomib and carfilzomib were administered at home to 54 patients with AML, myelodysplastic syndrome (MDS) or MM. A median of 17 (IQR 13–19) days of admission per patient and a total of 239 visits to the Hematology day-care hospital were avoided. Overall, 28 patients (14% of all episodes) needed admission to the hospital, 4 of them due to COVID-19. CONCLUSIONS: Implementation of a Hematology HAH unit was feasible and safe, and provided thorough advanced care to a high-risk population. Advanced care-at-home strategies can be crucial during times of COVID-19 to minimize treatment interruptions and reduce the risk of cross-infections. |
format | Online Article Text |
id | pubmed-8457036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-84570362021-09-23 Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility Gómez-Centurión, Ignacio Oarbeascoa, Gillen García, María Carmen López Fresneña, María Carmen Martínez Carreño, María Josefa Escudero Vilaplana, Vicente González-Haba, Eva Bailén, Rebeca Dorado, Nieves Juárez, Luis Miguel Rodríguez Macías, Gabriela Font López, Patricia Encinas, Cristina Bastos-Oreiro, Mariana Anguita, Javier Sanjurjo, María Díez-Martin, José Luis Kwon, Mi Int J Hematol Original Article BACKGROUND: “Hospital-at-home” (HAH) programs have been shown to optimize resource utilization, shorten hospitalization and prevent nosocomial infection. METHODS: We retrospectively analysed data regarding implementation of an HAH unit for caring patients with hematological malignancies in our center, during the COVID-19 pandemic. RESULTS: Between January and November 2020, 105 patients were treated in the HAH unit for a total of 204 episodes. Nine patients with multiple myeloma (MM) received autologous HSCT (auto-HSCT). Three patients with acute myeloid leukemia (AML) received consolidation therapy, 32 patients underwent clinical and analytical monitoring, 20 were transplant recipients early discharged (5 auto-HSCT and 15 allo-HSCT) and 2 had received CART cells therapy. Azacitidine, bortezomib and carfilzomib were administered at home to 54 patients with AML, myelodysplastic syndrome (MDS) or MM. A median of 17 (IQR 13–19) days of admission per patient and a total of 239 visits to the Hematology day-care hospital were avoided. Overall, 28 patients (14% of all episodes) needed admission to the hospital, 4 of them due to COVID-19. CONCLUSIONS: Implementation of a Hematology HAH unit was feasible and safe, and provided thorough advanced care to a high-risk population. Advanced care-at-home strategies can be crucial during times of COVID-19 to minimize treatment interruptions and reduce the risk of cross-infections. Springer Singapore 2021-09-22 2022 /pmc/articles/PMC8457036/ /pubmed/34553338 http://dx.doi.org/10.1007/s12185-021-03219-2 Text en © Japanese Society of Hematology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Gómez-Centurión, Ignacio Oarbeascoa, Gillen García, María Carmen López Fresneña, María Carmen Martínez Carreño, María Josefa Escudero Vilaplana, Vicente González-Haba, Eva Bailén, Rebeca Dorado, Nieves Juárez, Luis Miguel Rodríguez Macías, Gabriela Font López, Patricia Encinas, Cristina Bastos-Oreiro, Mariana Anguita, Javier Sanjurjo, María Díez-Martin, José Luis Kwon, Mi Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility |
title | Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility |
title_full | Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility |
title_fullStr | Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility |
title_full_unstemmed | Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility |
title_short | Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility |
title_sort | implementation of a hospital-at-home (hah) unit for hematological patients during the covid-19 pandemic: safety and feasibility |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457036/ https://www.ncbi.nlm.nih.gov/pubmed/34553338 http://dx.doi.org/10.1007/s12185-021-03219-2 |
work_keys_str_mv | AT gomezcenturionignacio implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT oarbeascoagillen implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT garciamariacarmen implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT lopezfresnenamariacarmen implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT martinezcarrenomariajosefa implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT escuderovilaplanavicente implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT gonzalezhabaeva implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT bailenrebeca implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT doradonieves implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT juarezluismiguel implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT rodriguezmaciasgabriela implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT fontlopezpatricia implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT encinascristina implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT bastosoreiromariana implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT anguitajavier implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT sanjurjomaria implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT diezmartinjoseluis implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility AT kwonmi implementationofahospitalathomehahunitforhematologicalpatientsduringthecovid19pandemicsafetyandfeasibility |